FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2597298059> ?p ?o ?g. }

• W2597298059 abstract "Abstract Introduction: Defining the optimal treatment strategy for elderly patients (pts) with diffuse large cell lymphoma (DLCL) represents a major challenge, since age, end-organ damage and comorbidities often preclude the delivery of full-dose intensive therapy. Objective means to prospectively identify those pts who can be safely treated with a curative intent are still lacking. We have analysed the performance of a comprehensive geriatric assessment (CGA) in defining those elderly DLCL pts which could tolerate an intensive and potentially curative treatment approach. Methods: In addition to staging procedures, in all consecutive pts aged >65 with newly diagnosed DLCL a CGA was prospectively performed, including assessment of activity of daily living (ADL), instrumental ADL (IADL), comorbidity score, and geriatric syndrome, and pts were classified in the category of “fit” vs “frail”, i.e. potentially able vs unable to tolerate intensive treatment. However the decision to treat pts with intensive, anthracyclin-based, chemotherapy (CT) (CHOP/CHOP-like regimens +/− Rituximab) vs palliation (radiotherapy, low-dose CT or corticosteroids) was based on staging and clinical judgement only, irrespective of the results of CGA. Results: From January 2003 to December 2006, 88 pts aged >65 were consecutively diagnosed with DLCL at our Institution and 84 had fully evaluable data. Their median age was 73 (range 66–89), 66% were in stage III-IV, 32% had B symptoms and 63% had an IPI score int-high or high. Based on clinical judgement, 62 pts (74%) received full-dose therapy and 22 received palliation. The proportion of pts treated aggressively was identical to that recorded in elderly DLCL pts diagnosed between 1995 and 2002. Their response rate (RR) (79,7% vs 55%; P=0.042), 2-year progression-free survival (PFS) (55,9% vs 22,2%; P=0.0002) and overall survival (OS) (57,7% vs 26,1%; P=0.0014) were significantly better compared to pts receiving palliation. According to CGA, 42 pts were classified as “fit” (50%) and 42 as “frail” (50%). The two subgroups significantly differed in mean age (70,8 vs 76,3; P<0.001) but not in lymphoma-related prognostic variables, including IPI and stage.”Fit” pts obtained significantly better RR (92,5% vs 48,8%; P<0.0001), 2-year PFS (73,4% vs 21,7%; P<0.0001) and OS (77,6% vs 23,8%; P<0.0001) compared to “frail” pts. Based on clinical judgement, all pts classified as “fit” as well as 20 of 42 pts classified as “frail” by CGA were treated aggressively, with curative intent. Remarkably, the 20 “frail” pts actually receiving aggressive treatment fared as poor as those given palliation only (2-year OS: 19,8% vs 26,1%; P= 0.85), lymphoma rather than toxicity being the main cause of failure also in this subgroup. Overall, the survival of patients identified by CGA as “fit” was significantly better compared to that of pts treated intensively based on clinical judgement only, both after 2003 (P=0.049) and between 1995 and 2002 (P=0.027). Conclusion: By CGA approximately one half of unselected elderly pts with DLCL are classified as “fit” and one half as “frail”. Compared to clinical judgement, performing a CGA seems a more effective and objective tool to prospectively identify those pts which can be safely treated with full-dose immuno-CT and can achieve an outcome similar to that of younger DLCL pts. Alternative approaches to the category of pts identified as “frail” are warranted." @default.
• W2597298059 created "2017-03-23" @default.
• W2597298059 creator A5014648735 @default.
• W2597298059 creator A5026990551 @default.
• W2597298059 creator A5034123305 @default.
• W2597298059 creator A5038660271 @default.
• W2597298059 creator A5065443409 @default.
• W2597298059 creator A5076236981 @default.
• W2597298059 date "2007-11-16" @default.
• W2597298059 modified "2023-09-26" @default.
• W2597298059 title "A Comprehensive Geriatric Assessment Is More Effective Than Clinical Judgement to Prospectively Identify Elderly Patients with Diffuse Large Cell Lymphoma Who Can Tolerate Full-Dose Anthracyclin-Based Treatment and Achieve the Same Outcome as Young Patients." @default.
• W2597298059 doi "https://doi.org/10.1182/blood.v110.11.3441.3441" @default.
• W2597298059 hasPublicationYear "2007" @default.
• W2597298059 type Work @default.
• W2597298059 sameAs 2597298059 @default.
• W2597298059 citedByCount "1" @default.
• W2597298059 countsByYear W25972980592012 @default.
• W2597298059 crossrefType "journal-article" @default.
• W2597298059 hasAuthorship W2597298059A5014648735 @default.
• W2597298059 hasAuthorship W2597298059A5026990551 @default.
• W2597298059 hasAuthorship W2597298059A5034123305 @default.
• W2597298059 hasAuthorship W2597298059A5038660271 @default.
• W2597298059 hasAuthorship W2597298059A5065443409 @default.
• W2597298059 hasAuthorship W2597298059A5076236981 @default.
• W2597298059 hasConcept C121608353 @default.
• W2597298059 hasConcept C126322002 @default.
• W2597298059 hasConcept C2776694085 @default.
• W2597298059 hasConcept C2776907518 @default.
• W2597298059 hasConcept C2777319248 @default.
• W2597298059 hasConcept C2778559949 @default.
• W2597298059 hasConcept C2779338263 @default.
• W2597298059 hasConcept C2780653079 @default.
• W2597298059 hasConcept C509974204 @default.
• W2597298059 hasConcept C535046627 @default.
• W2597298059 hasConcept C71924100 @default.
• W2597298059 hasConceptScore W2597298059C121608353 @default.
• W2597298059 hasConceptScore W2597298059C126322002 @default.
• W2597298059 hasConceptScore W2597298059C2776694085 @default.
• W2597298059 hasConceptScore W2597298059C2776907518 @default.
• W2597298059 hasConceptScore W2597298059C2777319248 @default.
• W2597298059 hasConceptScore W2597298059C2778559949 @default.
• W2597298059 hasConceptScore W2597298059C2779338263 @default.
• W2597298059 hasConceptScore W2597298059C2780653079 @default.
• W2597298059 hasConceptScore W2597298059C509974204 @default.
• W2597298059 hasConceptScore W2597298059C535046627 @default.
• W2597298059 hasConceptScore W2597298059C71924100 @default.
• W2597298059 hasLocation W25972980591 @default.
• W2597298059 hasOpenAccess W2597298059 @default.
• W2597298059 hasPrimaryLocation W25972980591 @default.
• W2597298059 hasRelatedWork W1972771318 @default.
• W2597298059 hasRelatedWork W2148613344 @default.
• W2597298059 hasRelatedWork W2185930966 @default.
• W2597298059 hasRelatedWork W2338351021 @default.
• W2597298059 hasRelatedWork W2412897853 @default.
• W2597298059 hasRelatedWork W2532879803 @default.
• W2597298059 hasRelatedWork W2625742257 @default.
• W2597298059 hasRelatedWork W3128698023 @default.
• W2597298059 hasRelatedWork W3177815677 @default.
• W2597298059 hasRelatedWork W4251229708 @default.
• W2597298059 isParatext "false" @default.
• W2597298059 isRetracted "false" @default.
• W2597298059 magId "2597298059" @default.
• W2597298059 workType "article" @default.